Figure 2.

Mean scores (±SE) of clinical outcome measures for placebo responders and nonresponders. A, Clinician administered outcome measures: patients having a posttreatment (day 56) score of 1–2 on the CGI-I were classified as responders (n = 10), and remaining patients (CGI-I ≥ 3) as nonresponders (n = 15). The two groups did not differ initially, but responders scored significantly lower on the LSAS at posttreatment. B, Social anxiety self-report instruments: After treatment, responders and nonresponders were significantly differentiated on the SPS, SIAS, and fear ratings during the scanned public speaking task.